Eslicarbazepine Acetate

規格

236395-14-5CAS番号

636-617-2EC番号

[(5S)-11-carbamoyl-5,6-dihydrobenzo[b][1]benzazepin-5-yl] acetateIUPAC名

C17H16N2O3化学式

296.32 g/mol分子量

Eslicarbazepine acetate; 236395-14-5; BIA 2-093; Zebinix; Aptiom; Exalief; Stedesa; Erelib; Pazzul; BIA-2-093; SEP-0002093; BEA68ZVB2K; CHEBI:87016; 5H-Dibenz[b,f]azepine-5-carboxamide, 10-(acetyloxy)-10,11-dihydro-, (10S)-; BIA-2093; SEP0002093; DTXSID90178308; (10S)-5-carbamoyl-10,11-dihydro-5H-dibenzo[b,f]azepin-10-yl acetate; (10S)-10-acetoxy-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide; 5H-DIBENZ(B,F)AZEPINE-5-CARBOXAMIDE, 10-(ACETYLOXY)-10,11-DIHYDRO-, (10S)-; (10S)-10-acetoxy-10,11-dihydro-5H-dibenz(b,f)azepine-5-carboxamide; (10S)-5-CARBAMOYL-10,11-DIHYDRO-5H-DIBENZO(B,F)AZEPIN-10-YL ACETATE; RefChem:56795; DTXCID80100799; (9S)-2-carbamoyl-2-azatricyclo(9.4.0.03,?)pentadeca-1(15),3,5,7,11,13-hexaen-9-yl acetate; 10-Acetoxy-10,11-dihydro-5H-dibenz(b,f)azepine-5-carboxamide; (S)-5-Carbamoyl-10,11-dihydro-5H-dibenzo[b,f]azepin-10-yl acetate; Eslicarbazepine (acetate); MFCD06798333; Eslicarbazepine acetate [USAN]; [(5S)-11-carbamoyl-5,6-dihydrobenzo[b][1]benzazepin-5-yl] acetate; CHEMBL87992; exelief; SEP - 0002093; (S)-(-)-10-Acetoxy-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide; (S)-10-Acetoxy- 10,11-dihydro- 5H-dibenz[b,f]azepine- 5-carboxamide; Eslicarbazepine acetate (USAN); S-(-)-10-Acetoxy-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide; Sep 0002093; UNII-BEA68ZVB2K; BIA 2093; Zebinix (TN); Aptiom (TN); EslicarbazepineAcetate; Eslicarbazepin acetate; eslicarbazepine-acetate; Eslicarbazapine Acetate; Epitope ID:423619; (10S)-10-(Acetyloxy)-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide; SCHEMBL250594; orb1225562; orb1304346; SCHEMBL29360562; HMS3263M06; HMS3885N14; HY-B0703; ESLICARBAZEPINE ACETATE [MI]; Tox21_501102; BDBM50240669; EBC-26508; MSK165345; s4657; AKOS005145781; CCG-222406; DB09119; ESLICARBAZEPINE ACETATE [MART.]; ESLICARBAZEPINE ACETATE [VANDF]; FE22807; LP01102; SDCCGSBI-0633789.P001; ESLICARBAZEPINE ACETATE [WHO-DD]; NCGC00165752-01; NCGC00165752-02; NCGC00165752-03; NCGC00165752-04; NCGC00165752-06; NCGC00261787-01; AC-31734; AS-14058; DA-73203; ESLICARBAZEPINE ACETATE [EMA EPAR]; SY028889; E1046; ESLICARBAZEPINE ACETATE [ORANGE BOOK]; NS00010246; BIA 2-093, >=98% (HPLC), solid; D09612; H11471; AR-270/43507894; EN300-18665321; F463334; Q410273; BRD-K61237927-001-01-7; (S)-(-)-10-Acetoxy-10,11-dihydro-5H-dibenz[b,f]azepine-5-carb oxamide; (S)-10-acetoxy-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carbimidic acid; (S)-10-ACETOXY-10,11-DIHYDRO-5HDIBENZ( B,F)AZEPINE-5-CARBOXAMIDE; 5-(aminocarbonyl)-10,11-dihydro-5H-dibenzo[b,f]azepin-10-yl acetate; 5H-Dibenz9b,f)azepine-5-carboxamide, 10-(acetyloxy)-10,11-dihydro-, (10S)-; Acetic acid (S)-5-carbamoyl-10,11-dihydro-5H-dibenzo[b,f]azepin-10-yl ester; (9S)-2-carbamoyl-2-azatricyclo[9.4.0.0,3,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-9-yl acetate; Eslicarbazepine Acetate(micronized)別名